These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 30707284)
1. [Current and experimental treatment approaches for neurotrophic keratopathy]. Alder J; Mertsch S; Menzel-Severing J; Geerling G Ophthalmologe; 2019 Feb; 116(2):127-137. PubMed ID: 30707284 [TBL] [Abstract][Full Text] [Related]
2. Neurotrophic keratopathy: current challenges and future prospects. NaPier E; Camacho M; McDevitt TF; Sweeney AR Ann Med; 2022 Dec; 54(1):666-673. PubMed ID: 35243932 [TBL] [Abstract][Full Text] [Related]
3. Neurotrophic keratopathy. Dua HS; Said DG; Messmer EM; Rolando M; Benitez-Del-Castillo JM; Hossain PN; Shortt AJ; Geerling G; Nubile M; Figueiredo FC; Rauz S; Mastropasqua L; Rama P; Baudouin C Prog Retin Eye Res; 2018 Sep; 66():107-131. PubMed ID: 29698813 [TBL] [Abstract][Full Text] [Related]
4. Neurotrophic keratopathy: An updated understanding. Neurotrophic Keratopathy Study Group Ocul Surf; 2023 Oct; 30():129-138. PubMed ID: 37666470 [TBL] [Abstract][Full Text] [Related]
5. CORNEAL NEUROTIZATION IN A PATIENT WITH SEVERE NEUROTROPHIC KERATOPATHY. CASE REPORT. Rusňák Š; Hecová L; Štěpánek D; Sobotová M Cesk Slov Oftalmol; 2021; 77(3):146–152. PubMed ID: 35130706 [TBL] [Abstract][Full Text] [Related]
6. The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review. Ruiz-Lozano RE; Hernandez-Camarena JC; Loya-Garcia D; Merayo-Lloves J; Rodriguez-Garcia A Ocul Surf; 2021 Jan; 19():224-240. PubMed ID: 33022412 [TBL] [Abstract][Full Text] [Related]
7. Cenegermin for the treatment of neurotrophic keratitis. Sacchetti M; Bruscolini A; Lambiase A Drugs Today (Barc); 2017 Nov; 53(11):585-595. PubMed ID: 29451275 [TBL] [Abstract][Full Text] [Related]
9. Corneal neurotization in the management of neurotrophic keratopathy: A review of the literature. Saad S; Labani S; Goemaere I; Cuyaubere R; Borderie M; Borderie V; Benkhatar H; Bouheraoua N J Fr Ophtalmol; 2023 Jan; 46(1):83-96. PubMed ID: 36473789 [TBL] [Abstract][Full Text] [Related]
10. Advances in the Medical Management of Neurotrophic Keratitis. Dohlman TH; Singh RB; Dana R Semin Ophthalmol; 2021 May; 36(4):335-340. PubMed ID: 33705259 [TBL] [Abstract][Full Text] [Related]
12. A Novel Treatment for Neurotrophic Corneal Ulcer Using Topical Cenegermin (OXERVATE™) Containing Recombinant Human Nerve Growth Factor. Ahuja AS; Bowden FW; Robben JL Cureus; 2020 Nov; 12(11):e11724. PubMed ID: 33391953 [TBL] [Abstract][Full Text] [Related]
13. In Vivo Confocal Microscopy Reveals Corneal Reinnervation After Treatment of Neurotrophic Keratopathy With Corneal Neurotization. Fung SSM; Catapano J; Elbaz U; Zuker RM; Borschel GH; Ali A Cornea; 2018 Jan; 37(1):109-112. PubMed ID: 29053558 [TBL] [Abstract][Full Text] [Related]
14. Assessment of response to multimodal management of neurotrophic corneal disease. Trinh T; Santaella G; Mimouni M; Mednick Z; Cohen E; Sorkin N; Rootman DS; Slomovic AR; Chan CC Ocul Surf; 2021 Jan; 19():330-335. PubMed ID: 33189904 [TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis and epidemiology of neurotrophic keratopathy]. Mertsch S; Alder J; Dua HS; Geerling G Ophthalmologe; 2019 Feb; 116(2):109-119. PubMed ID: 30478498 [TBL] [Abstract][Full Text] [Related]
16. Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy. Hamrah P; Yavuz Saricay L; Ozmen MC Cornea; 2022 Jun; 41(6):673-679. PubMed ID: 35266655 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of neurotrophic keratopathy in combined lesions of the trigeminal and facial nerves]. Gushchina MB; Butsan SB; Salikhov KS; Sergeeva VY Vestn Oftalmol; 2022; 138(3):102-109. PubMed ID: 35801888 [TBL] [Abstract][Full Text] [Related]